Certainly, a specific CpG island methylator phenotype in gliomas and colorectal cancers that is characterized by DNA hypermethylation has been associated with IDH mutations, which has led to several speculations that IDH mutations contribute to tumorigenesis via altered epigenetic regulation (43–45). Here, IDH2 is linked to central nervous system cancer.